Literature DB >> 18481943

Experimental models of beta-cell regeneration.

Claire Bonal1, Isabelle Avril, Pedro L Herrera.   

Abstract

The control of glucose metabolism by pancreatic endocrine cells throughout life relies on a tight regulation of the mass of insulin-producing beta-cells. How this homoeostasis is achieved is not well understood. Over the last few years, experimental rodent models with altered beta-cell mass, and, more recently, new transgenic approaches designed to tackle this problem, have provided abundant information. Processes such as beta-cell proliferation and apoptosis, or even beta-cell differentiation from poorly characterized progenitor cells, whether immature or differentiated, appear to be implicated. A complex picture is thus emerging in which the nature of the pancreatic lesion appears to determine the kind of regenerative response. The environment formed by acinar and ductal cells, and also by vascular and neuronal structures, which surround islets and penetrate into their beta-cell core, might play crucial roles so far unsuspected, which should be explored in the near future.

Entities:  

Mesh:

Year:  2008        PMID: 18481943     DOI: 10.1042/BST0360286

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  4 in total

Review 1.  Cellular origins of beta-cell regeneration: a legacy view of historical controversies.

Authors:  A Granger; J A Kushner
Journal:  J Intern Med       Date:  2009-10       Impact factor: 8.989

2.  Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model.

Authors:  M Jiménez-González; F Jaques; S Rodríguez; A Porciuncula; R M Principe; G Abizanda; M Iñiguez; J Escalada; J Salvador; F Prósper; P A Halban; M Barajas
Journal:  Diabetologia       Date:  2013-01-29       Impact factor: 10.122

Review 3.  Pancreatic β-cell identity in diabetes.

Authors:  M S Remedi; C Emfinger
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

4.  Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study.

Authors:  Nidheesh Dadheech; Abhay Srivastava; Neha Paranjape; Shivika Gupta; Arpita Dave; Girish M Shah; Ramesh R Bhonde; Sarita Gupta
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.